Notify me when ExodusPoint Capital Management, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 6.3% | $28,675,722 | 1,907,899 | ExodusPoint Capital Management, LP | 10 Nov 2025 | ||
| ALTS | ALT5 Sigma Corp | Common Stock, $0.001 par value per share | 4.8% | $48,903,445 | 5,856,700 | ExodusPoint Capital Management, LP | 11 Aug 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|